Gerald Gellermann

767 total citations
9 papers, 638 citations indexed

About

Gerald Gellermann is a scholar working on Molecular Biology, Physiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gerald Gellermann has authored 9 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Physiology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gerald Gellermann's work include Alzheimer's disease research and treatments (6 papers), Protein purification and stability (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Gerald Gellermann is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Protein purification and stability (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Gerald Gellermann collaborates with scholars based in Germany, Switzerland and United States. Gerald Gellermann's co-authors include Thomas Appel, Stephan Diekmann, Marcus Fändrich, Peter Hortschansky, Christoph Röcken, Peter Davies, Uwe Horn, Astrid Tannert, Jessica Meinhardt and Christian Haupt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Molecular Biology and Biotechnology and Bioengineering.

In The Last Decade

Gerald Gellermann

9 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerald Gellermann Germany 7 475 404 101 81 78 9 638
Karin Wieligmann Germany 9 509 1.1× 387 1.0× 68 0.7× 99 1.2× 67 0.9× 12 691
Monica M. Pallitto United States 5 528 1.1× 557 1.4× 51 0.5× 154 1.9× 124 1.6× 5 780
Tong‐Lay Lau Australia 8 353 0.7× 405 1.0× 25 0.2× 86 1.1× 70 0.9× 9 633
Carsten Krantz Switzerland 6 292 0.6× 435 1.1× 36 0.4× 68 0.8× 114 1.5× 8 554
Isam Qahwash United States 8 376 0.8× 458 1.1× 22 0.2× 68 0.8× 94 1.2× 10 655
Ruitian Liu United States 10 269 0.6× 292 0.7× 79 0.8× 69 0.9× 77 1.0× 13 530
Janet C. Saunders United Kingdom 5 280 0.6× 239 0.6× 22 0.2× 67 0.8× 44 0.6× 7 441
Dhiman Ghosh Switzerland 13 456 1.0× 289 0.7× 33 0.3× 55 0.7× 20 0.3× 22 878
Thomas Lauber Germany 9 250 0.5× 238 0.6× 27 0.3× 29 0.4× 58 0.7× 15 508
Hamed Shaykhalishahi Germany 13 258 0.5× 338 0.8× 21 0.2× 65 0.8× 30 0.4× 19 556

Countries citing papers authored by Gerald Gellermann

Since Specialization
Citations

This map shows the geographic impact of Gerald Gellermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Gellermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Gellermann more than expected).

Fields of papers citing papers by Gerald Gellermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald Gellermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Gellermann. The network helps show where Gerald Gellermann may publish in the future.

Co-authorship network of co-authors of Gerald Gellermann

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald Gellermann. A scholar is included among the top collaborators of Gerald Gellermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald Gellermann. Gerald Gellermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Nerkamp, Jörg, et al.. (2023). Using enhanced development tools offered by analytical Quality by Design to support switching of a quality control method. Biotechnology and Bioengineering. 120(11). 3299–3310. 3 indexed citations
2.
Ringler, Philippe, Alexandra Graff-Meyer, Henning Stahlberg, et al.. (2016). Characterization of mAb dimers reveals predominant dimer forms common in therapeutic mAbs. mAbs. 8(5). 928–940. 38 indexed citations
3.
Cromwell, Mary, Christof Finkler, Gerald Gellermann, et al.. (2016). Establishing a control system using QbD principles. Biologicals. 44(5). 319–331. 32 indexed citations
4.
Gellermann, Gerald, et al.. (2008). Aβ-globulomers are formed independently of the fibril pathway. Neurobiology of Disease. 30(2). 212–220. 92 indexed citations
5.
Gellermann, Gerald, et al.. (2007). Identification of molecular compounds critical to Alzheimer's‐like plaque formation. Journal of Neuroscience Research. 85(9). 2037–2044. 3 indexed citations
6.
Haupt, Christian, Ralf P. Friedrich, Peter Hortschansky, et al.. (2007). Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Aβ protofibrils. Proceedings of the National Academy of Sciences. 104(49). 19232–19237. 196 indexed citations
7.
Gellermann, Gerald, Astrid Tannert, Peter Hortschansky, et al.. (2006). Alzheimer-like Plaque Formation by Human Macrophages Is Reduced by Fibrillation Inhibitors and Lovastatin. Journal of Molecular Biology. 360(2). 251–257. 26 indexed citations
8.
Gellermann, Gerald, Thomas Appel, Peter Davies, & Stephan Diekmann. (2006). Paired helical filaments contain small amounts of cholesterol, phosphatidylcholine and sphingolipids. Biological Chemistry. 387(9). 78 indexed citations
9.
Gellermann, Gerald, Thomas Appel, Astrid Tannert, et al.. (2005). Raft lipids as common components of human extracellular amyloid fibrils. Proceedings of the National Academy of Sciences. 102(18). 6297–6302. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karin Wieligmann Breakdown of academic impact, for papers by Monica M. Pallitto Breakdown of academic impact, for papers by Tong‐Lay Lau Breakdown of academic impact, for papers by Carsten Krantz Breakdown of academic impact, for papers by Isam Qahwash Breakdown of academic impact, for papers by Ruitian Liu Breakdown of academic impact, for papers by Janet C. Saunders Breakdown of academic impact, for papers by Dhiman Ghosh Breakdown of academic impact, for papers by Thomas Lauber Breakdown of academic impact, for papers by Hamed Shaykhalishahi
Rankless by CCL
2026